Compare Sun Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA CIPLA SUN PHARMA/
CIPLA
 
P/E (TTM) x 32.0 28.8 111.3% View Chart
P/BV x 4.2 4.0 105.5% View Chart
Dividend Yield % 0.9 0.6 166.4%  

Financials

 SUN PHARMA   CIPLA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
CIPLA
Mar-21
SUN PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs654879 74.4%   
Low Rs339411 82.5%   
Sales per share (Unadj.) Rs139.6237.6 58.8%  
Earnings per share (Unadj.) Rs9.529.8 32.0%  
Cash flow per share (Unadj.) Rs18.242.2 43.1%  
Dividends per share (Unadj.) Rs7.505.00 150.0%  
Avg Dividend yield %1.50.8 194.9%  
Book value per share (Unadj.) Rs193.6226.7 85.4%  
Shares outstanding (eoy) m2,399.34806.46 297.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.62.7 131.0%   
Avg P/E ratio x52.121.6 240.7%  
P/CF ratio (eoy) x27.315.3 178.6%  
Price / Book Value ratio x2.62.8 90.1%  
Dividend payout %78.816.8 469.0%   
Avg Mkt Cap Rs m1,190,430519,826 229.0%   
No. of employees `000NANA-   
Total wages/salary Rs m68,62232,518 211.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,981191,596 174.8%  
Other income Rs m8,5922,698 318.5%   
Total revenues Rs m343,573194,294 176.8%   
Gross profit Rs m41,61641,841 99.5%  
Depreciation Rs m20,80010,031 207.3%   
Interest Rs m1,4141,607 88.0%   
Profit before tax Rs m27,99432,901 85.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1478,888 57.9%   
Profit after tax Rs m22,84724,013 95.1%  
Gross profit margin %12.421.8 56.9%  
Effective tax rate %18.427.0 68.1%   
Net profit margin %6.812.5 54.4%  
BALANCE SHEET DATA
Current assets Rs m304,421132,095 230.5%   
Current liabilities Rs m161,45645,916 351.6%   
Net working cap to sales %42.745.0 94.9%  
Current ratio x1.92.9 65.5%  
Inventory Days Days14968 220.3%  
Debtors Days Days997 1,504.1%  
Net fixed assets Rs m336,682116,277 289.6%   
Share capital Rs m2,3991,613 148.8%   
"Free" reserves Rs m462,229181,232 255.0%   
Net worth Rs m464,628182,844 254.1%   
Long term debt Rs m8,98112,028 74.7%   
Total assets Rs m641,103248,372 258.1%  
Interest coverage x20.821.5 96.8%   
Debt to equity ratio x00.1 29.4%  
Sales to assets ratio x0.50.8 67.7%   
Return on assets %3.810.3 36.7%  
Return on equity %4.913.1 37.4%  
Return on capital %6.217.7 35.1%  
Exports to sales %031.3 0.0%   
Imports to sales %010.9 0.0%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs mNA20,911 0.0%   
Fx inflow Rs m84,49368,051 124.2%   
Fx outflow Rs m30,33420,911 145.1%   
Net fx Rs m54,15947,140 114.9%   
CASH FLOW
From Operations Rs m61,70437,552 164.3%  
From Investments Rs m5,362-23,872 -22.5%  
From Financial Activity Rs m-59,805-13,299 449.7%  
Net Cashflow Rs m5,964509 1,171.5%  

Share Holding

Indian Promoters % 54.5 14.3 380.4%  
Foreign collaborators % 0.0 21.8 -  
Indian inst/Mut Fund % 33.8 45.8 73.8%  
FIIs % 12.1 24.8 48.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 63.9 71.3%  
Shareholders   675,908 410,831 164.5%  
Pledged promoter(s) holding % 6.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   LINK PHARMA  JUBILANT INGREVIA  CAPLIN POINT  NORRIS MEDICINES  J.B.CHEMICALS  



Today's Market

Sensex Up 400 Points, Nifty Above 18,250; Tech Mahindra & Tata Motors Surge 5%(10:30 am)

Asian share markets are trading higher today, boosted by gains in US shares that hit record highs as Tesla topped US$1 tn in value.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 26, 2021 10:56 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS